Preproliferative Diabetic Retinopathy Subclassification and Glycemic Control Relationship Between Mean Hemoglobin A1C Value and Development of Proliferative Diabetic Retinopathy

التفاصيل البيبلوغرافية
العنوان: Preproliferative Diabetic Retinopathy Subclassification and Glycemic Control Relationship Between Mean Hemoglobin A1C Value and Development of Proliferative Diabetic Retinopathy
المؤلفون: Yukihiro Sato, Zeon Lee, Yohichi Hayashi
المصدر: Japanese Journal of Ophthalmology. 45:678
بيانات النشر: Elsevier BV, 2001.
سنة النشر: 2001
مصطلحات موضوعية: medicine.medical_specialty, endocrine system diseases, business.industry, Preproliferative diabetic retinopathy, General Medicine, Diabetic retinopathy, medicine.disease, Gastroenterology, Sub classification, Ophthalmology, Internal medicine, Medicine, Hemoglobin, business, Value (mathematics), Glycemic
الوصف: PURPOSE We evaluated the relationship between long-term glycemic control and the proportion of patients developing proliferative diabetic retinopathy(PDR) in cases of mild preproliferative diabetic retinopathy(PPDR). MATERIALS AND METHODS We evaluated the relationship between the mean hemoglobin A1C (HbA1C) value during a period of at least 2 years and the proportion of patients developing PDR in cases of mild PPDR, based on our previously proposed subclassification. RESULTS During follow-up, 27% of all cases developed PDR. The mean HbA1C value in these cases was 9.4%, which was significantly higher than the 7.6% in cases which had not developed PDR. The proportion of patients developing PDR was 48% in cases with a mean HbA1C value 8.6% or more. In contrast, the proportion was 8% in cases with a mean HbA1C value below 8.6%. It was estimated that the proportion of patients developing PDR will approximately double if the mean HbA1C value increases by one percent. The cumulative occurrence rates of PDR at two, 5, and 10 years were estimated to be 5, 28, and 60% in cases with a mean HbA1C value 8.6% or more and 0, 7, and 10% in cases with a mean HbA1C value below 8.6%, respectively. CONCLUSION Based on the above results, we conclude that more strict systemic and ophthalmological control is indicated for patients with a mean HbA1C value exceeding 8.6%.
تدمد: 0021-5155
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b33e7348f4e2fc28eae8b6e3996abc6d
https://doi.org/10.1016/s0021-5155(01)00433-6
حقوق: CLOSED
رقم الأكسشن: edsair.doi...........b33e7348f4e2fc28eae8b6e3996abc6d
قاعدة البيانات: OpenAIRE